Literature DB >> 33021698

Spasticity distribution and severity in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Matheus Sales1,2, Giselle Bárbara de Almeida Scaldaferri3, Juliana Iris Barbosa Dos Santos3, Ailton Melo3,4, Nildo Manoel da Silva Ribeiro3,5,6.   

Abstract

In individuals with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), spasticity is one of the main symptoms. The neurological signs of the disease are well defined, but details of how spasticity appears in these individuals have not been well explored. To describe spasticity location and severity of HAM/TSP individuals. Cross-sectional study with individuals older than 18 years, diagnosed with HAM/TSP and with lower limb spasticity. Pregnant women, individuals with other associated neurological diseases, and those using antispastic drugs were not included. Spasticity was assessed by the Modified Ashworth Scale (MAS), applied to the abductor, adductor, flexor, and extensor muscles of the hips, flexors, and extensors of the knees, dorsiflexors, plantiflexors, evertors, and inverters of the foot. Thirty participants were included. The plantiflexor muscles (90%), knee extensors (80%), knee flexors (63,3%), and adductors (50%) were most frequently affected by spasticity. Twenty-three (76.7%) individuals had mixed spasticity, 5 (16.7%) with distal spasticity and 2 (6.7%) with proximal spasticity. MAS was similar between the lower limbs in at least 6 of the 10 muscle groups of each individual. Spasticity was mostly mixed in the lower limbs, with more frequently mild severity. The individuals were partially symmetrical between the lower limbs. The most affected muscle groups were the plantiflexors, knee extensors and flexors and the hip adductors, consecutively, being predominantly symmetrical.
© 2020. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  HTLV-I infections; HTLV-I-associated myelopathy; Muscle spasticity; Tropical spastic paraparesis

Mesh:

Year:  2020        PMID: 33021698     DOI: 10.1007/s13365-020-00911-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  21 in total

Review 1.  The HTLV-1 neurological complex.

Authors:  Abelardo Q C Araujo; Marcus Tulius T Silva
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

2.  Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

Authors:  Carlos M De Castro-Costa; Abelardo Q C Araújo; Márcio M Barreto; Osvaldo M Takayanagui; Marzia P Sohler; Eduardo L M da Silva; Sônia M B de Paula; Ricardo Ishak; João G R Ribas; Luis C Rovirosa; Herwig Carton; Eduardo Gotuzzo; William W Hall; Silvia Montano; Edward L Murphy; Joel Oger; Carlos Remondegui; Graham P Taylor
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

Review 3.  Special Considerations in Assessing and Treating Spasticity in Spinal Cord Injury.

Authors:  John Lin; Wesley Chay
Journal:  Phys Med Rehabil Clin N Am       Date:  2018-05-28       Impact factor: 1.784

4.  Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study.

Authors:  B Galvão-Castro; L Loures; L G Rodriques; A Sereno; O C Ferreira Júnior; L G Franco; M Muller; D A Sampaio; A Santana; L M Passos; F Proietti
Journal:  Transfusion       Date:  1997-02       Impact factor: 3.157

5.  Impact of specific symptoms of spasticity on voluntary lower limb muscle function, gait and daily activities during subacute and chronic spinal cord injury.

Authors:  E Bravo-Esteban; J Taylor; J Abián-Vicén; S Albu; C Simón-Martínez; D Torricelli; J Gómez-Soriano
Journal:  NeuroRehabilitation       Date:  2013       Impact factor: 2.138

6.  Neuropathology of HTLV-1-associated myelopathy (HAM/TSP): The 50th Anniversary of Japanese Society of Neuropathology.

Authors:  Shuji Izumo
Journal:  Neuropathology       Date:  2010-10       Impact factor: 1.906

7.  Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.

Authors:  G A S Dias; G T Yoshikawa; R V L Koyama; S Fujihara; L C S Martins; R Medeiros; J A S Quaresma; H T Fuzii
Journal:  Spinal Cord       Date:  2015-07-14       Impact factor: 2.772

8.  Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis.

Authors:  E Gotuzzo; J Cabrera; L Deza; K Verdonck; A-M Vandamme; R Cairampoma; D Vizcarra; M Cabada; G Narvarte; C De las Casas
Journal:  Clin Infect Dis       Date:  2004-09-01       Impact factor: 9.079

9.  Balance, functional mobility, and fall occurrence in patients with human T-cell lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis: a cross-sectional study.

Authors:  Erika Pedreira da Fonseca; Katia Nunes Sá; Rebeca Freitas Reis Nunes; Antônio Carlos Ribeiro Junior; Síntia Freitas Bastos Lira; Elen Beatriz Pinto
Journal:  Rev Soc Bras Med Trop       Date:  2018 Mar-Apr       Impact factor: 1.581

10.  Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load.

Authors:  Michel E Haziot; M Rita Gascon; Tatiane Assone; Luiz Augusto M Fonseca; Olinda do Carmo Luiz; Jerusa Smid; Arthur M Paiva; Rosa Maria do N Marcusso; A C Penalva de Oliveira; Jorge Casseb
Journal:  PLoS Negl Trop Dis       Date:  2019-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.